Investors Bullish on 3 stocks $PFE $NVS $CHL Based on Bollinger Band

*If You Own PFE, NVS, CHL Then Click Here to Join Our Community Of Traders

The Market Signal was created as a platform to help investors, if you own (NYSE:PFE), (NYSE:NVS) or (NYSE:CHL) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/ Free-Report/NOW

(Click link above or copy, paste and hit enter in your browser for your report)

Pfizer signs agreement with OTTAWA Canada for early delivery of coronavirus vaccine

https://themarketsignal.com/Free-Report/PFE

(Click link above or copy, paste and hit enter in your browser for your report)

Pfizer Inc. (NYSE:PFE) 20 Days Bollinger Band $33.63 is below the last trading price, and the price currently looks bullish.

OTTAWA Canada entered into an agreement with Pfizer and Moderna Inc (NASDAQ: MRNA) for early supply of millions of doses of their coronavirus vaccine that is still under development. Moderna is working on its mRNA-1273 vaccine while Pfizer has partnered with BioNTech SE from German to develop BNT162 mRNA-based vaccine.

All vaccines supply will first seek Health Canada regulatory approval. The two drugs are very promising in the fight against the pandemic. UK is another country that has signed agreements for delivery of 90 million doses of vaccines that are under development by various companies among them Valneva SE, BioNTech SE, and Pfizer.

Novartis reports successful Phase II trial of CAR-T

https://themarketsignal.com/Free-Report/NVS

(Click link above or copy, paste and hit enter in your browser for your report)

Novartis AG (NYSE:NVS) 20 Days Bollinger Band $82.05 is below the last trading price, and the price currently looks bullish.

After reporting successful Phase II trial of CAR-T in slow-growing lymphoma, Novartis will be seeking regulatory approval for commercialization. The study met its primary endpoint although the company did not disclose data from the trial. The company will be seeking regulatory approval from the FDA and EMA in 2021.

Phase II ELARA study of Kymriah (tisagenlecleucel) used to treat patients with refractory or relapsed follicular lymphoma met its primary endpoint. Novartis will partner with Sangamo to offer gene therapies for autism. Using Sangamo's zinc-finger technology the two companies will also develop 3-neurodevelopmental targets. As part of the deal, Novartis will pay $75 million to Sangamo.

China Mobile to launch 5G network to more regions

https://themarketsignal.com/Free-Report/CHL

(Click link above or copy, paste and hit enter in your browser for your report)

China Mobile Ltd. (NYSE:CHL) 20 Days Bollinger Band $33.65 is below the last trading price, and the price currently looks bullish.

China Mobile has announced that it has added 14.4 million subscribers in the month of June. The company had 70.2 million 5G subscribers as of June, 2020. China Mobile had 6.7 million 5G subscribers in January. Cumulatively, the company's user base has grown to 946.7 million as of end of June 2020 from 935 million in June 2019. The telco's main target is to install 232,000 5G base stations as it seeks to increase its coverage to 28 regions in china.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

The post Investors Bullish on 3 stocks $PFE $NVS $CHL Based on Bollinger Band appeared first on The Market Signals.

comtex tracking

COMTEX_368976289/2700/2020-08-06T09:23:18

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.